Enrichment-free Salmonella detection for food safety

用于食品安全的无富集沙门氏菌检测

基本信息

  • 批准号:
    9409755
  • 负责人:
  • 金额:
    $ 48.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-12 至 2017-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Each year over one million people become ill due to foodborne Salmonella infections, this accounts for a total of 11% of all foodborne illness reported in the United States1. Salmonella is the leading cause for foodborne illness hospitalizations (23,000 cases; 35%) and deaths (450 cases; 28%). Salmonella has an enormous impact on the economy, causing $3.7 billion in costs in the United States each year; 90% of this burden ($3.3 million) is due to deaths, 8% ($294 million) due to hospitalizations and 2% due to non-hospitalized cases. The primary mode of Salmonella infection is through food, mainly raw or undercooked meat, raw eggs and unwashed vegetables. These illnesses are often tied to outbreaks that result from contaminated food that was not detected at a manufacturing or packaging plant. Current detection methods for Salmonella provide slow time to actionable results, making it difficult to take necessary steps in controlling the pathogen. Sample6 has developed a new technology, based on the proprietary Bioillumination PlatformTM, which utilizes a novel synthetic engineering approach to leverage the natural specificity of bacteriophage to detect the presence of specific bacterial species. Sample6 DETECT/S system contains engineered bacteriophages, which can identify Salmonella spp. to induce production of luminescent enzymes, upon infection of the target cells, effectively illuminating Salmonella. This signal can be measured with the Sample6 Luminometer and instantiates the world's first enrichment-free pathogen diagnostic system. Sample6 has previously established feasibility that the DETECT/S assay can be adapted for finished product testing to detect Salmonella directly on food products that are prone to contamination. For this Direct-to- Phase II project, we propose to complete the development of our technology to detect Salmonella on additional foods to achieve validation as laid out in AOAC guidelines. We will expand the testing to include 400 Salmonella isolates belonging to clinically relevant serotypes, and complete assay development for 20 food matrices representing all commercially relevant categories, including low-moisture foods. Finally, we will develop non-replicating phage technology for our BioIllumination Platform to further increase our reach in the market, both domestically and internationally.
项目概要/摘要 每年有超过一百万人因食源性沙门氏菌感染而患病,这 占美国报告的所有食源性疾病的 11%1。沙门氏菌是 食源性疾病住院(23,000 例;35%)和死亡(450 例)的主要原因 案例; 28%)。沙门氏菌对经济造成巨大影响,造成 37 亿美元的损失 每年在美国;该负担的 90%(330 万美元)是由于死亡,8%(294 美元) 百万)由于住院病例和 2% 由于非住院病例。主要模式为 沙门氏菌是通过食物感染的,主要是生的或未煮熟的肉、生鸡蛋和未洗的肉 蔬菜。这些疾病通常与受污染食品引起的疾病爆发有关。 未在制造或包装工厂检测到。目前的检测方法 沙门氏菌导致获得可行结果的时间很慢,因此很难采取必要的措施 控制病原体。 Sample6 开发了一项新技术,基于专有技术 生物照明平台TM,利用新颖的合成工程方法来利用 噬菌体的天然特异性可检测特定细菌种类的存在。样品6 DETECT/S 系统包含工程噬菌体,可以识别沙门氏菌属。到 在感染靶细胞后,有效诱导发光酶的产生 阐明沙门氏菌。该信号可以使用 Sample6 发光计进行测量, 实例化了世界上第一个无浓缩病原体诊断系统。 Sample6 之前有 确定 DETECT/S 测定可适用于成品测试的可行性 直接检测易受污染的食品上的沙门氏菌。对于这个直接到 二期项目,我们建议完成沙门氏菌检测技术的开发 AOAC 指南中规定的其他食品以实现验证。我们将扩大 测试包括 400 个属于临床相关血清型的沙门氏菌分离株,并完成 代表所有商业相关类别的 20 种食品基质的测定开发, 包括低水分食物。最后,我们将开发非复制噬菌体技术 生物照明平台进一步扩大我们在国内外市场的影响力 国际上。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Sandor Koeris其他文献

Michael Sandor Koeris的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Sandor Koeris', 18)}}的其他基金

Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy
将噬菌体介导的去定植与微生物植入相结合,促进龈上微生物组的持续调节,以增强抗龋齿治疗
  • 批准号:
    10307172
  • 财政年份:
    2021
  • 资助金额:
    $ 48.95万
  • 项目类别:
Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy
将噬菌体介导的去定植与微生物植入相结合,促进龈上微生物组的持续调节,以增强抗龋齿治疗
  • 批准号:
    10080641
  • 财政年份:
    2020
  • 资助金额:
    $ 48.95万
  • 项目类别:
Phage-Based Blood Test to Detect Bacterial Infections at the Point of Care
基于噬菌体的血液检测可在护理点检测细菌感染
  • 批准号:
    9568943
  • 财政年份:
    2017
  • 资助金额:
    $ 48.95万
  • 项目类别:
Adaptation of an enrichment-free Listeria diagnostic to food matrices
将无富集李斯特菌诊断方法应用于食品基质
  • 批准号:
    9346485
  • 财政年份:
    2017
  • 资助金额:
    $ 48.95万
  • 项目类别:
Adaptation of enrichment-free Listeria diagnostic to food matrices
免富集李斯特菌诊断对食品基质的适应
  • 批准号:
    9046705
  • 财政年份:
    2015
  • 资助金额:
    $ 48.95万
  • 项目类别:

相似海外基金

Water Emergency Team (WET): Community-Driven Rapid Response Team to Evaluate Antibiotic-Resistant Bacteria Exposures and Household Environmental Health Risks from Sewer Overflows and Basement Flooding
水应急小组 (WET):社区驱动的快速响应小组,评估下水道溢出和地下室洪水导致的抗生素耐药细菌暴露和家庭环境健康风险
  • 批准号:
    10686675
  • 财政年份:
    2023
  • 资助金额:
    $ 48.95万
  • 项目类别:
Effects and mechanisms of cold-induced stress on the development of Chlamydia muridarum genital infection in a mouse model
寒冷应激对鼠衣原体生殖道感染小鼠模型的影响及机制
  • 批准号:
    10730819
  • 财政年份:
    2023
  • 资助金额:
    $ 48.95万
  • 项目类别:
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center
气道疾病暴露组分析以解开哮喘疾病的决定因素 (EXPAND-Asthma) 中心
  • 批准号:
    10744673
  • 财政年份:
    2023
  • 资助金额:
    $ 48.95万
  • 项目类别:
The roles of fosfomycin resistant subpopulations of Escherichia coli in urinary tract infection.
大肠杆菌磷霉素耐药亚群在尿路感染中的作用。
  • 批准号:
    10603417
  • 财政年份:
    2023
  • 资助金额:
    $ 48.95万
  • 项目类别:
Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
  • 批准号:
    10726417
  • 财政年份:
    2023
  • 资助金额:
    $ 48.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了